Cyclacel Pharmaceuti (CYCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYCC | AZN | AMGN | GILD | VRTX |
| Company | Cyclacel Pharmaceuti | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 6.76 | 177.67 | 344.38 | 125.85 | 462.17 |
| High | 6.98 | 177.80 | 345.00 | 126.39 | 464.98 |
| Low | 6.10 | 173.66 | 334.20 | 122.43 | 450.44 |
| Latest | 6.37 | 174.94 | 334.59 | 122.73 | 452.29 |
| Change | -0.41 | -2.95 | -7.07 | -2.72 | -6.70 |
| % Change | -5.98% | -1.66% | -2.07% | -2.17% | -1.46% |
| Volume | 220,400 | 1,011,068 | 2,184,264 | 3,525,704 | 811,194 |
| 20-Day Average Volume | 87,150 | 1,973,056 | 2,731,457 | 8,242,663 | 1,285,141 |
| Previous Close | 6.77 | 177.89 | 341.66 | 125.45 | 458.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.56 | 181.78 | 341.30 | 128.78 | 442.33 |
| 20-Day Raw Stochastic | 12.79% | 7.27% | 37.61% | 10.82% | 73.28% |
| 20-Day Relative Strength | 39.78 | 40.55 | 46.64 | 39.62 | 54.80 |
| Weighted Alpha | -91.36 | +15.35 | +12.65 | +6.33 | +5.12 |
| Today's Opinion | 100% Sell | 72% Sell | 8% Sell | 72% Sell | 40% Buy |
| Previous Opinion | 100% Sell | 56% Sell | 24% Buy | 72% Sell | 40% Buy |
| Last Month's Opinion | 56% Sell | 24% Sell | 24% Sell | 24% Sell | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.68% since 09/04/25 | -4.00% since 06/11/26 | -5.13% since 06/11/26 | -2.20% since 06/11/26 | +1.68% since 06/11/26 |
| Low | 5.92 on 09/10/25 | 173.70 on 06/18/26 | 334.20 on 06/18/26 | 122.43 on 06/18/26 | 439.50 on 06/15/26 |
| High | 7.49 on 09/05/25 | 182.70 on 06/12/26 | 358.30 on 06/15/26 | 128.20 on 06/17/26 | 464.39 on 06/18/26 |
| 1-Month | |||||
| %Chg | -29.67% since 08/11/25 | -4.86% since 05/18/26 | +3.55% since 05/18/26 | -5.07% since 05/18/26 | +3.65% since 05/18/26 |
| Low | 5.92 on 09/10/25 | 173.70 on 06/18/26 | 320.96 on 05/19/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 9.52 on 08/13/25 | 191.50 on 05/21/26 | 358.46 on 06/11/26 | 137.20 on 05/29/26 | 464.39 on 06/18/26 |
| 3-Month | |||||
| %Chg | +34.45% since 06/11/25 | -7.13% since 03/18/26 | -4.43% since 03/18/26 | -12.87% since 03/18/26 | +0.21% since 03/18/26 |
| Low | 3.08 on 07/07/25 | 173.70 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 19.87 on 07/24/25 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 464.39 on 06/18/26 |
| 6-Month | |||||
| %Chg | -91.51% since 03/11/25 | -3.44% since 12/18/25 | +3.54% since 12/18/25 | +1.34% since 12/18/25 | +1.15% since 12/18/25 |
| Low | 3.08 on 07/07/25 | 173.70 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 100.75 on 04/28/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,251 | 275,891,008 | 184,396,640 | 155,754,944 | 116,493,952 |
| Shares Outstanding, K | 2,239 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 40,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -11,210,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -1,320,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 0.15 | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.98 on 08/13/25 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 11/11/25 | 08/04/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | 0.150 on 04/29/25 | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | 04/29/25 | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.30 | 15.74 | 15.20 | 26.94 |